Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Malignant Tumour”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT05910112
What this trial is testing

Prospective Data Collection on Clinical, Radiological and Patient Reported Outcomes After Pleural Intervention

Who this might be right for
Pleural DiseasesPleural MesotheliomaPneumothorax+7 more
University of Oxford 2,000
Not applicableStudy completedNCT02356471
What this trial is testing

Consumer-Based Activity Monitor in Evaluating and Measuring Activity of Older Patients With Abdominal Cancer Undergoing Surgery

Who this might be right for
Malignant Gastrointestinal NeoplasmMalignant Peritoneal Neoplasm
Wake Forest University Health Sciences 34
Not applicableActive Not RecruitingNCT05941299
What this trial is testing

Safety and Performance of REGENERA Breast Implant in Women Affected by Malignant Breast Lesion Treated by Lumpectomy

Who this might be right for
Mastectomy, SegmentalBreast Neoplasm Malignant Female
Tensive SRL 92
Early research (Phase 1)UnknownNCT00006216
What this trial is testing

Vaccine Therapy and Ganciclovir in Treating Patients With Mesothelioma

Who this might be right for
Malignant Mesothelioma
Louisiana State University Health Sciences Center in New Orleans
Testing effectiveness (Phase 2)Active Not RecruitingNCT06351371
What this trial is testing

Testing JNJ-42756493 (Erdafitinib) as Potentially Targeting Treatment in Cancers With FGFR Mutations or Fusions (MATCH - Subprotocol K2)

Who this might be right for
Malignant Solid Neoplasm
National Cancer Institute (NCI) 35
Not applicableUnknownNCT05237193
What this trial is testing

A Prospective Study of UCAD for Diagnosing Benign or Malignant Biliary Obstruction and Follow-up

Who this might be right for
Biliary Tract NeoplasmsPancreatic CarcinomaGallbladder Cancer+1 more
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine 400
Not applicableActive Not RecruitingNCT07531121
What this trial is testing

CtDNA for Risk Stratification in Melanoma

Who this might be right for
Melanoma (Skin Cancer)
Herlev and Gentofte Hospital 296
Testing effectiveness (Phase 2)Ended earlyNCT01264081
What this trial is testing

Lapatinib in Stage IV Melanoma With ERBB4 Mutations

Who this might be right for
Malignant Melanoma
National Cancer Institute (NCI) 34
Not applicableStudy completedNCT02345798
What this trial is testing

Video-Assisted Intervention in Improving Recovery in Patients With Cancer Undergoing Lung Surgery and Caregivers

Who this might be right for
Malignant Lung Neoplasm
City of Hope Medical Center 73
Early research (Phase 1)Study completedNCT04617314
What this trial is testing

RC108-ADC in Subjects With Advanced Malignant Solid Tumors

Who this might be right for
Solid Tumor
RemeGen Co., Ltd. 67
Not applicableEnrolling By InvitationNCT07567716
What this trial is testing

Infiltration Pattern of Locally Advanced ESCC

Who this might be right for
Esophageal Squamous Cell Carcinoma (ESCC)InfiltrationTumour
Shanghai Chest Hospital 30
Not applicableEnded earlyNCT06068738
What this trial is testing

Association of Ex Vivo Drug Response (EVDR) and Clinical Outcome in Ovarian Cancer

Who this might be right for
Epithelial Ovarian Cancer
Exscientia AI Limited 13
Testing effectiveness (Phase 2)Active Not RecruitingNCT03175432
What this trial is testing

Bevacizumab and Atezolizumab With or Without Cobimetinib in Treating Patients With Untreated Melanoma Brain Metastases

Who this might be right for
BRAF V600 Wild TypeClinical Stage IV Cutaneous Melanoma AJCC v8Intracranial Melanoma+4 more
M.D. Anderson Cancer Center 29
Testing effectiveness (Phase 2)Looking for participantsNCT03800693
What this trial is testing

2 Versus 6 Hour Oxaliplatin Infusions in Patients With Gastrointestinal Cancers

Who this might be right for
Malignant Digestive System Neoplasm
Emory University 60
Not applicableStudy completedNCT01775514
What this trial is testing

A Non-Interventional Study of the Occurrence Rate of Non-Small Cell Lung Cancer, Colon Cancer, Breast Cancer, Gastric Cancer and Malignant Melanoma in Turkey, and Diagnosis and Treatment Characteristics

Who this might be right for
Cancer
Hoffmann-La Roche 32,277
Not applicableStudy completedNCT02527304
What this trial is testing

Adaptive Staged Stereotactic Body Radiation Therapy in Treating Patients With Spinal Metastases That Cannot Be Removed by Surgery

Who this might be right for
MelanomaMetastatic Malignant Neoplasm in the SpineRenal Cell Carcinoma+2 more
Albert Einstein College of Medicine 24
Early research (Phase 1)Study completedNCT00456495
What this trial is testing

Effect of Ranibizumab on Malignant Conjunctival Neoplasia

Who this might be right for
Conjunctival Neoplasms
The New York Eye Cancer Center 5
Not applicableEnded earlyNCT07082257
What this trial is testing

Precision Performance Status Compared With ECOG Performance Status

Who this might be right for
Hematopoietic and Lymphatic System NeoplasmMalignant Solid Neoplasm
University of Southern California 41
Post-approval studies (Phase 4)Looking for participantsNCT06353529
What this trial is testing

Postop Pain Management in Pituitary Tumour Patients

Who this might be right for
PituitaryPain, Postoperative
Hamilton Health Sciences Corporation 108
Not applicableActive Not RecruitingNCT01806129
What this trial is testing

Reproductive Health Program in Patients With Cancer

Who this might be right for
Malignant Neoplasm
ECOG-ACRIN Cancer Research Group 434
Next Page